Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics

30 Jun 2023

Abstract excerpt

One of the most pressing challenges associated with SARS-CoV-2 treatment is the emergence of new variants that may be more transmissible, cause more severe disease, or be resistant to current treatments and vaccines. The emergence of SARS-CoV-2 has led to a global pandemic, resulting in millions of deaths worldwide. Various strategies have been employed to combat the virus, including neutralizing monoclonal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37406505
DOI: 10.1016/j.biopha.2023.115099

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeuticsPMID 37406505Read ↗

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and InfluenzaSemantic proximity Read ↗

TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)Semantic proximity Read ↗

A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense TherapySemantic proximity Read ↗

Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 InfectionSemantic proximity Read ↗

CRISPR/Cas13: A potential therapeutic option of COVID-19Semantic proximity Read ↗

Novel Antiviral Therapeutic Against SARS-CoV-2 and its Variants: Recent Developments and Future PerspectivesSemantic proximity Read ↗

Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19Semantic proximity Read ↗

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 VariantsSemantic proximity Read ↗

Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsSemantic proximity Read ↗

Aptamer‐based strategies against SARS‐CoV‐2 virusesSemantic proximity Read ↗

Insights into SARS-CoV-2 evolution, potential antivirals, and vaccinesSemantic proximity Read ↗

An Overview of Basic Molecular Biology of SARS-CoV-2 and Current COVID-19 Prevention Strategies<strong> </strong>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.